Literature DB >> 23847251

Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage.

Bruce Ovbiagele1, Jeffrey J Wing, Ravi S Menon, Richard E Burgess, M Christopher Gibbons, Ian Sobotka, Laura German, Nawar M Shara, Stephen Fernandez, Annapurni Jayam-Trouth, Dorothy Farrar Edwards, Chelsea S Kidwell.   

Abstract

BACKGROUND AND
PURPOSE: To investigate the relationship between chronic kidney disease (CKD) and MRI-defined cerebral microbleeds (CMB), a harbinger of future intracerebral hemorrhage (ICH), among patients with a recent history of primary ICH.
METHODS: Using data from a predominantly black cohort of patients with a recent ICH-enrolled in an observational study between September 2007 and June 2011, we evaluated the association between CKD (defined as estimated low glomerular filtration rate<60 mL/min per 1.73 m(2)) and CMB on gradient-echo MRI. Multivariable models were generated to determine the contribution of CKD to the presence, number, and location of CMB.
RESULTS: Of 197 subjects with imaging data, mean age was 59 years, 48% were women, 73% were black, 114 (58%) had ≥1 CMBs, and 52 (26%) had CKD. Overall, CKD was associated with presence of CMB (adjusted odds ratio, 2.70; 95% confidence interval [CI], 1.10-6.59) and number of CMB (adjusted relative risk, 2.04; 95% CI, 1.27-3.27). CKD was associated with CMB presence (adjusted odds ratio, 3.44; 95% CI, 1.64-7.24) and number (adjusted relative risk, 2.46; 95% CI, 1.11-5.42) in black patients, but not CMB presence (adjusted odds ratio, 3.00; 95% CI, 0.61-14.86) or number (adjusted relative risk, 1.03; 95% CI: 0.22-4.89) in non-Hispanic white patients (interactions by race were statistically not significant).
CONCLUSIONS: CKD is associated with a greater presence and number of CMB in ICH patients, particularly in patients of black race. Future studies should assess whether low estimated glomerular filtration rate may be a CMB risk marker or potential therapeutic target for mitigating the development of CMB.

Entities:  

Keywords:  MRI; antihypertensive therapy; black; cerebral hemorrhage; cerebral microbleeds; hemorrhagic stroke; prevalence; renal; renal insufficiency, chronic; renin–angiotensin; stroke

Mesh:

Year:  2013        PMID: 23847251     DOI: 10.1161/STROKEAHA.113.001958

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  27 in total

1.  High rate of microbleed formation following primary intracerebral hemorrhage.

Authors:  Jason Mackey; Jeffrey J Wing; Gina Norato; Ian Sobotka; Ravi S Menon; Richard E Burgess; M Chris Gibbons; Nawar M Shara; Stephen Fernandez; Annapurni Jayam-Trouth; Laura Russell; Dorothy F Edwards; Chelsea S Kidwell
Journal:  Int J Stroke       Date:  2015-08-26       Impact factor: 5.266

2.  Renal dysfunction is associated with deep cerebral microbleeds but not white matter hyperintensities in patients with acute intracerebral hemorrhage.

Authors:  Mona Laible; Solveig Horstmann; Markus Möhlenbruch; Christian Wegele; Timolaos Rizos; Svenja Schüler; Markus Zorn; Roland Veltkamp
Journal:  J Neurol       Date:  2015-07-15       Impact factor: 4.849

Review 3.  Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Authors:  Tatjana S Potpara; Charles J Ferro; Gregory Y H Lip
Journal:  Nat Rev Nephrol       Date:  2018-03-26       Impact factor: 28.314

Review 4.  Neurologic Complications of Chronic Kidney Disease.

Authors:  Kavitha Vellanki; Vinod K Bansal
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 5.081

Review 5.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

6.  Assessment of cerebral microbleeds by susceptibility-weighted imaging at 3T in patients with end-stage organ failure.

Authors:  Gianvincenzo Sparacia; Roberto Cannella; Vincenzina Lo Re; Angelo Gambino; Giuseppe Mamone; Roberto Miraglia
Journal:  Radiol Med       Date:  2018-02-17       Impact factor: 3.469

7.  Impaired renal function is related to deep and mixed, but not strictly lobar cerebral microbleeds in patients with ischaemic stroke and TIA.

Authors:  Gargi Banerjee; Kolawole W Wahab; Simone M Gregoire; Fatima Jichi; Andreas Charidimou; Hans R Jäger; Khadija Rantell; David J Werring
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849

Review 8.  Management of Atrial Fibrillation in Patients With Kidney Disease.

Authors:  Yee C Lau; Gregory Y H Lip
Journal:  J Atr Fibrillation       Date:  2014-04-30

9.  The Risk of Major Hemorrhage with CKD.

Authors:  Amber O Molnar; Sarah E Bota; Amit X Garg; Ziv Harel; Ngan Lam; Eric McArthur; Gihad Nesrallah; Jeffrey Perl; Manish M Sood
Journal:  J Am Soc Nephrol       Date:  2016-01-28       Impact factor: 10.121

10.  Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial.

Authors:  Ashkan Shoamanesh; Andrea Morotti; Javier M Romero; Jamary Oliveira-Filho; Frieder Schlunk; Michael J Jessel; Alison M Ayres; Anastasia Vashkevich; Kristin Schwab; Mohammad R Afzal; Christy Cassarly; Renee H Martin; Adnan I Qureshi; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein
Journal:  JAMA Neurol       Date:  2018-07-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.